Drugs / mRNA-1018 for H5N8
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05972174 | Jul 2023 → Jul 2024 | influenza | ModernaTX, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mRNA-1018 for H5N8 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05972174 ↗ |
| Route | Intramuscular | “by intramuscular (IM) injection” NCT05972174 ↗ |